Advances in the Diagnosis, Molecular Genetics, and Treatment of Pediatric Embryonal CNS Tumors

Advances in the Diagnosis, Molecular Genetics, and Treatment of Pediatric Embryonal CNS Tumors Tobey J. MacDonald, Brian R. Rood, Maria R. Santi, Gilbert Vezina, Kimberly Bingaman, Philip H. Cogen, Roger J. Packer Oncologist 2003; 8: 174-186 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in pediatric oncology and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Recognize the classification, clinical presentation, and diagnosis of embryonal CNS tumors. Explain the important molecular genetic alterations identified in embryonal CNS tumors. Describe the current management and novel treatment strategies for embryonal CNS tumors. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Apr. 11, 2003 Most Recent Review: Apr. 11, 2003* Most Recent Update: Apr. 11, 2003 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.